NCT02894840View on ClinicalTrials.gov

Safety and Immunogenicity of GPO Seasonal Trivalent Inactivated Influenza Vaccine in Healthy Thai Adults

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

340

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

November 30, 2016

Conditions
Influenza
Interventions
BIOLOGICAL

an inactivated influenza vaccine

The vaccine will be administered via the intramuscular route; the preferred injection site will be the deltoid of the non-dominant arm.

OTHER

Placebo

The placebo will be administered via the intramuscular route; the preferred injection site will be the deltoid of the non-dominant arm.

All Listed Sponsors
collaborator

The Government Pharmaceutical Organization

OTHER_GOV

collaborator

World Health Organization

OTHER

lead

Mahidol University

OTHER

NCT02894840 - Safety and Immunogenicity of GPO Seasonal Trivalent Inactivated Influenza Vaccine in Healthy Thai Adults | Biotech Hunter | Biotech Hunter